A detailed history of Banco Santander, S.A. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Banco Santander, S.A. holds 151,107 shares of OCUL stock, worth $1.06 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
151,107
Previous 172,231 12.26%
Holding current value
$1.06 Million
Previous $1.5 Million 13.89%
% of portfolio
0.02%
Previous 0.02%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

SELL
$8.33 - $11.47 $175,962 - $242,292
-21,124 Reduced 12.26%
151,107 $1.29 Million
Q3 2024

Nov 12, 2024

SELL
$6.45 - $9.23 $1.32 Million - $1.89 Million
-205,137 Reduced 54.36%
172,231 $1.5 Million
Q2 2024

Jul 29, 2024

BUY
$4.2 - $8.69 $710,522 - $1.47 Million
169,172 Added 81.26%
377,368 $2.58 Million
Q1 2024

May 10, 2024

SELL
$3.85 - $10.93 $1.28 Million - $3.63 Million
-332,280 Reduced 61.48%
208,196 $1.89 Million
Q4 2023

Feb 09, 2024

BUY
$2.08 - $4.52 $297,508 - $646,509
143,033 Added 35.99%
540,476 $2.41 Million
Q2 2023

Aug 14, 2023

BUY
$4.6 - $7.64 $595,948 - $989,792
129,554 Added 48.36%
397,443 $2.05 Million
Q1 2023

May 10, 2023

SELL
$2.79 - $6.27 $168,585 - $378,864
-60,425 Reduced 18.4%
267,889 $1.41 Million
Q4 2022

Feb 13, 2023

SELL
$2.61 - $4.41 $63,937 - $108,031
-24,497 Reduced 6.94%
328,314 $922,000
Q3 2022

Nov 08, 2022

SELL
$4.09 - $6.5 $830,568 - $1.32 Million
-203,073 Reduced 36.53%
352,811 $1.46 Million
Q2 2022

Jul 28, 2022

BUY
$3.01 - $5.22 $1.67 Million - $2.9 Million
555,884 New
555,884 $2.24 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $539M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.